Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer. [electronic resource]
Producer: 20171030Description: 3449-3457 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Anemia -- chemically induced
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Diarrhea -- chemically induced
- Double-Blind Method
- Female
- Humans
- Ipilimumab
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Outcome Assessment, Health Care -- methods
- Paclitaxel -- administration & dosage
- Proportional Hazards Models
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.